NASDAQ:PETS PetMed Express - PETS Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding PetMed Express, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $16.41 -0.95 (-5.47%) (As of 03/22/2023 12:00 AM ET) Add Compare Share Share Today's Range$16.32▼$17.4850-Day Range$16.89▼$22.2252-Week Range$16.32▼$29.53Volume1.07 million shsAverage Volume449,041 shsMarket Capitalization$345.92 millionP/E Ratio28.79Dividend Yield7.31%Price Target$18.00 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media PetMed Express MarketRank™ ForecastAnalyst RatingReduce1.00 Rating ScoreUpside/Downside9.7% Upside$18.00 Price TargetShort InterestBearish19.92% of Shares Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings Growth92.31%From $0.39 to $0.75 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.52 out of 5 starsRetail/Wholesale Sector181st out of 207 stocksDrug Stores & Proprietary Stores Industry4th out of 5 stocks 0.5 Analyst's Opinion Consensus RatingPetMed Express has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no buy ratings, no hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $18.00, PetMed Express has a forecasted upside of 9.7% from its current price of $16.41.Amount of Analyst CoveragePetMed Express has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted19.92% of the outstanding shares of PetMed Express have been sold short.Short Interest Ratio / Days to CoverPetMed Express has a short interest ratio ("days to cover") of 11, which indicates bearish sentiment.Change versus previous monthShort interest in PetMed Express has recently decreased by 13.22%, indicating that investor sentiment is improving significantly. Previous Next 1.7 Dividend Strength Dividend LeadershipPetMed Express is a leading dividend payer. It pays a dividend yield of 6.93%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthPetMed Express does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of PetMed Express is 210.53%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on EPS estimates, PetMed Express will have a dividend payout ratio of 160.00% in the coming year. This indicates that PetMed Express may not be able to sustain their current dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PETS. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for PetMed Express this week, compared to 3 articles on an average week.Search Interest37 people have searched for PETS on MarketBeat in the last 30 days. This is an increase of 208% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added PetMed Express to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, PetMed Express insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.10% of the stock of PetMed Express is held by insiders.Percentage Held by Institutions77.74% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for PetMed Express are expected to grow by 92.31% in the coming year, from $0.39 to $0.75 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of PetMed Express is 28.79, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 120.17.Price to Earnings Ratio vs. SectorThe P/E ratio of PetMed Express is 28.79, which means that it is trading at a less expensive P/E ratio than the Retail/Wholesale sector average P/E ratio of about 34.33.Price to Book Value per Share RatioPetMed Express has a P/B Ratio of 2.42. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About PetMed Express (NASDAQ:PETS) StockPetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.Read More Receive PETS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter. Email Address PETS Stock News HeadlinesMarch 22, 2023 | markets.businessinsider.comPerformance of OncoK9® in Real-World Veterinary Practice Mirrors Clinical Validation StudyMarch 9, 2023 | marketwatch.comPet Product E-commerce Market New Innovations and Future Expansion 2023-2029March 22, 2023 | Oxford Club (Ad)My No. 1 dividend stock for a LIFETIME of income.Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.February 24, 2023 | finance.yahoo.comInvestors in PetMed Express (NASDAQ:PETS) have unfortunately lost 46% over the last five yearsFebruary 18, 2023 | marketwatch.comPet Care E-commerce Market Size Global Research Report, 2023 - 2028February 14, 2023 | forbes.comPetMed Express Buy Write Is Prescription For One-Month 77% Annualized Return PotentialFebruary 10, 2023 | finance.yahoo.comWhy PetMed Express Was a Dog of a Stock This WeekFebruary 10, 2023 | finance.yahoo.comPetMed Express (NASDAQ:PETS) Has Affirmed Its Dividend Of $0.30March 22, 2023 | Oxford Club (Ad)My No. 1 dividend stock for a LIFETIME of income.Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.February 8, 2023 | finance.yahoo.comPetMed Express, Inc. (NASDAQ:PETS) Q3 2022 Earnings Call TranscriptFebruary 7, 2023 | seekingalpha.comPetMed Express: Short Puts Make Much More SenseFebruary 7, 2023 | finanznachrichten.dePetMed Express, Inc.: PetMeds Announces Its Third Quarter Financial Results and Declares a Quarterly Dividend of $0.30 Per ShareFebruary 6, 2023 | msn.comPetMed Express falls after earnings fall short of expectations.February 6, 2023 | finance.yahoo.comStocks moving in after hours: Chegg, Petmed Express, Simon Property GroupFebruary 6, 2023 | msn.comPetMed Express GAAP EPS of $0.00 misses by $0.20, revenue of $58.9M misses by $3.13MFebruary 6, 2023 | finance.yahoo.comPetMeds® Announces Its Third Quarter Financial Results and Declares a Quarterly Dividend of $0.30 Per ShareFebruary 3, 2023 | seekingalpha.comPetMed Express Q3 2023 Earnings PreviewFebruary 3, 2023 | msn.comEarnings Preview: PetMed ExpressJanuary 31, 2023 | finance.yahoo.comPets at Home sees FY 2023 underlying pretax profit at upper end of consensusJanuary 30, 2023 | finance.yahoo.comIs PetMed Express, Inc.'s (NASDAQ:PETS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?January 25, 2023 | seekingalpha.comPETS PetMed Express, Inc.January 23, 2023 | finance.yahoo.comPetMed Express, Inc. Sets Third Quarter 2022 Earnings CallJanuary 18, 2023 | msn.comPeople are abandoning pets at airports. Don’t be like them.January 18, 2023 | marketwatch.comPets Digestive Enzymes Market Size 2023 : Expected To Deliver Dynamic Progression Until 2028January 17, 2023 | finance.yahoo.comPetMed Express buys PetCareRX for $36MJanuary 17, 2023 | msn.comDogs day out: Pets walk the ramp at Kolkata carnival | See picsJanuary 17, 2023 | markets.businessinsider.comPetMed Agrees To Acquire PetCareRxSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive PETS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter. Email Address PETS Company Calendar Last Earnings10/24/2021Ex-Dividend for 2/27 Dividend2/16/2023Dividend Payable2/27/2023Today3/22/2023Fiscal Year End3/31/2023Next Earnings (Estimated)5/08/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Drug stores & proprietary stores Sub-IndustryInternet Retail SectorRetail/Wholesale Current SymbolNASDAQ:PETS CUSIP71638210 CIK1040130 Webwww.1800petmeds.com Phone(561) 526-4444Fax561-526-4445Employees219Year Founded1996Price Target and Rating Average Stock Price Forecast$18.00 High Stock Price Forecast$18.00 Low Stock Price Forecast$18.00 Forecasted Upside/Downside+9.7%Consensus RatingReduce Rating Score (0-4)1.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$0.57 Trailing P/E Ratio28.79 Forward P/E Ratio42.08 P/E GrowthN/ANet Income$21.10 million Net Margins4.38% Pretax Margin5.78% Return on Equity8.54% Return on Assets7.00% Debt Debt-to-Equity RatioN/A Current Ratio4.31 Quick Ratio3.59 Sales & Book Value Annual Sales$273.42 million Price / Sales1.27 Cash Flow$1.11 per share Price / Cash Flow14.79 Book Value$6.78 per share Price / Book2.42Miscellaneous Outstanding Shares21,080,000Free Float20,220,000Market Cap$345.92 million OptionableOptionable Beta0.68 Social Links Key ExecutivesMatthew N. HulettPresident, Chief Executive Officer & DirectorChristine ChambersChief Financial OfficerMark MoseleyChief Technology & Information OfficerCarolyn CardenVice President-Product ManagementEddie KhoriatyDir-Pharmacy Services & Prescription Dept. ManagerKey CompetitorsRite AidNYSE:RADZumiezNASDAQ:ZUMZBig LotsNYSE:BIGDestination XL GroupNASDAQ:DXLGBiglariNYSE:BHView All CompetitorsInstitutional OwnershipLakewood Asset Management LLCBought 3,910 shares on 3/1/2023Ownership: 0.019%Truist Financial CorpBought 10,362 shares on 2/17/2023Ownership: 0.049%Alliancebernstein L.P.Bought 11,510 shares on 2/16/2023Ownership: 0.055%Legal & General Group PlcBought 1,395 shares on 2/15/2023Ownership: 0.251%Aspire Private Capital LLCBought 1,009 shares on 2/15/2023Ownership: 0.006%View All Institutional Transactions PETS Stock - Frequently Asked Questions Should I buy or sell PetMed Express stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" PETS shares. View PETS analyst ratings or view top-rated stocks. What is PetMed Express' stock price forecast for 2023? 1 analysts have issued 12 month price targets for PetMed Express' shares. Their PETS share price forecasts range from $18.00 to $18.00. On average, they expect the company's stock price to reach $18.00 in the next twelve months. This suggests a possible upside of 9.7% from the stock's current price. View analysts price targets for PETS or view top-rated stocks among Wall Street analysts. How have PETS shares performed in 2023? PetMed Express' stock was trading at $17.70 at the beginning of 2023. Since then, PETS stock has decreased by 7.3% and is now trading at $16.41. View the best growth stocks for 2023 here. Are investors shorting PetMed Express? PetMed Express saw a decrease in short interest during the month of February. As of February 28th, there was short interest totaling 4,200,000 shares, a decrease of 13.2% from the February 13th total of 4,840,000 shares. Based on an average daily trading volume, of 380,300 shares, the days-to-cover ratio is currently 11.0 days. View PetMed Express' Short Interest. When is PetMed Express' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023. View our PETS earnings forecast. How were PetMed Express' earnings last quarter? PetMed Express, Inc. (NASDAQ:PETS) announced its earnings results on Sunday, October, 24th. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by $0.03. The firm earned $67.39 million during the quarter, compared to analysts' expectations of $70.90 million. PetMed Express had a trailing twelve-month return on equity of 8.54% and a net margin of 4.38%. During the same quarter in the previous year, the firm posted $0.42 EPS. How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express? PetMed Express announced a quarterly dividend on Monday, February 6th. Investors of record on Monday, February 20th will be paid a dividend of $0.30 per share on Monday, February 27th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.31%. The ex-dividend date of this dividend is Thursday, February 16th. Read our dividend analysis for PETS. What ETFs hold PetMed Express' stock? ETFs with the largest weight of PetMed Express (NASDAQ:PETS) stock in their portfolio include Formidable ETF (FORH), Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD), Amplify Online Retail ETF (IBUY), Global SuperDividend US ETF (DIV), SPDR S&P Internet ETF (XWEB), ProShares Russell 2000 Dividend Growers ETF (SMDV), Roundhill Acquirers Deep Value ETF (DEEP) and RiverFront Dynamic US Dividend Advantage ETF (RFDA). Is PetMed Express a good dividend stock? PetMed Express (NASDAQ:PETS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 6.93%. PETS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 210.53%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, PETS will have a dividend payout ratio of 160.00% in the coming year. This indicates that the company may not be able to sustain their current dividend. Read our dividend analysis for PETS. What is Mendo Akdag's approval rating as PetMed Express' CEO? 5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of PetMed Express own? Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU). What is PetMed Express' stock symbol? PetMed Express trades on the NASDAQ under the ticker symbol "PETS." Who are PetMed Express' major shareholders? PetMed Express' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (4.43%), Charles Schwab Investment Management Inc. (2.96%), ProShare Advisors LLC (2.83%), Mirae Asset Global Investments Co. Ltd. (2.80%), Dimensional Fund Advisors LP (2.77%) and Geode Capital Management LLC (2.05%). Insiders that own company stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn. View institutional ownership trends. How do I buy shares of PetMed Express? Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is PetMed Express' stock price today? One share of PETS stock can currently be purchased for approximately $16.41. How much money does PetMed Express make? PetMed Express (NASDAQ:PETS) has a market capitalization of $345.92 million and generates $273.42 million in revenue each year. The company earns $21.10 million in net income (profit) each year or $0.57 on an earnings per share basis. How many employees does PetMed Express have? The company employs 219 workers across the globe. How can I contact PetMed Express? PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The official website for the company is www.1800petmeds.com. The company can be reached via phone at (561) 526-4444, via email at investor@petmeds.com, or via fax at 561-526-4445. This page (NASDAQ:PETS) was last updated on 3/22/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.